Sofia hCG FIA Field Study
- Conditions
- Pregnancy, Early Detection
- Registration Number
- NCT01803113
- Lead Sponsor
- Quidel Corporation
- Brief Summary
The objective of this field study is to demonstrate the clinical performance of the Sofia hCG FIA Test, using urine specimens from females of childbearing age.
- Detailed Description
Subjects presenting for pregnancy testing will provide urine specimens that will be tested with the Sofia hCG FIA test and the comparator pregnancy test that will detect levels of hCG of 20mIU as positive for pregnancy.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 975
- Female subjects of childbearing age, who are being screened for pregnancy and who have signed the informed consent
- Subject is post-menopausal.
- Subject within the past six weeks has experienced any of the following: delivered a newborn; had an abortion or a natural termination (miscarriage); or, received hCG supplements.
- Subject has had a hysterectomy.
- Unable to understand and consent to participation.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of presence of hCG in urine 1 day Clinical performance will be based on comparison of Sofia hCG FIA test results to those obtained from an FDA-cleared hCG test.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (5)
NECCR of Massachusetts, LLC
🇺🇸Fall River, Massachusetts, United States
Jose Castaneda, MD
🇺🇸Boynton Beach, Florida, United States
New England Center for Clinical Research Fall River,LLC (NECCR)
🇺🇸Fall River, Massachusetts, United States
Partners In Obstetrics and Gynecology, Inc.
🇺🇸Pawtucket, Rhode Island, United States
Planned Parenthood Gulf Coast
🇺🇸Houston, Texas, United States